Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.
from News Medical Medical Research News Feed https://ift.tt/3I4SBK4
0 Comments